These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 30391834)

  • 1. Sex, THC, and hormones: Effects on density and sensitivity of CB
    Farquhar CE; Breivogel CS; Gamage TF; Gay EA; Thomas BF; Craft RM; Wiley JL
    Drug Alcohol Depend; 2019 Jan; 194():20-27. PubMed ID: 30391834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional enhancement of cannabinoid CB₁ receptor desensitization in female adolescent rats following repeated Delta-tetrahydrocannabinol exposure.
    Burston JJ; Wiley JL; Craig AA; Selley DE; Sim-Selley LJ
    Br J Pharmacol; 2010 Sep; 161(1):103-12. PubMed ID: 20718743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gonadal hormones do not alter the development of antinociceptive tolerance to delta-9-tetrahydrocannabinol in adult rats.
    Wakley AA; Wiley JL; Craft RM
    Pharmacol Biochem Behav; 2015 Jun; 133():111-21. PubMed ID: 25863271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of gonadal hormones on cannabinoid dependence.
    Marusich JA; Craft RM; Lefever TW; Wiley JL
    Exp Clin Psychopharmacol; 2015 Aug; 23(4):206-16. PubMed ID: 26237318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-related changes in CB1 receptor expression and function and the behavioral effects of cannabinoid receptor ligands.
    Ginsburg BC; Hensler JG
    Pharmacol Biochem Behav; 2022 Feb; 213():173339. PubMed ID: 35077729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex, species and age: Effects of rodent demographics on the pharmacology of ∆
    Wiley JL; Barrus DG; Farquhar CE; Lefever TW; Gamage TF
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110064. PubMed ID: 32810571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex differences in cannabinoid 1 vs. cannabinoid 2 receptor-selective antagonism of antinociception produced by delta9-tetrahydrocannabinol and CP55,940 in the rat.
    Craft RM; Wakley AA; Tsutsui KT; Laggart JD
    J Pharmacol Exp Ther; 2012 Mar; 340(3):787-800. PubMed ID: 22182934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-arrestin2 regulates cannabinoid CB1 receptor signaling and adaptation in a central nervous system region-dependent manner.
    Nguyen PT; Schmid CL; Raehal KM; Selley DE; Bohn LM; Sim-Selley LJ
    Biol Psychiatry; 2012 Apr; 71(8):714-24. PubMed ID: 22264443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delta FosB and AP-1-mediated transcription modulate cannabinoid CB₁ receptor signaling and desensitization in striatal and limbic brain regions.
    Lazenka MF; David BG; Lichtman AH; Nestler EJ; Selley DE; Sim-Selley LJ
    Biochem Pharmacol; 2014 Oct; 91(3):380-9. PubMed ID: 25093286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of hippocampal CB1 receptor desensitization by Δ(9)-tetrahydrocannabinol in aged mice and by low doses of JZL 184.
    Feliszek M; Bindila L; Lutz B; Zimmer A; Bilkei-Gorzo A; Schlicker E
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):603-12. PubMed ID: 26984820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ΔFosB induction correlates inversely with CB₁ receptor desensitization in a brain region-dependent manner following repeated Δ⁹-THC administration.
    Lazenka MF; Selley DE; Sim-Selley LJ
    Neuropharmacology; 2014 Feb; 77():224-33. PubMed ID: 24090766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biphasic effects of Δ9-tetrahydrocannabinol on brain stimulation reward and motor activity.
    Katsidoni V; Kastellakis A; Panagis G
    Int J Neuropsychopharmacol; 2013 Nov; 16(10):2273-84. PubMed ID: 23830148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-related differences in the regional pattern of cannabinoid receptor adaptation and in vivo tolerance development to delta9-tetrahydrocannabinol.
    McKinney DL; Cassidy MP; Collier LM; Martin BR; Wiley JL; Selley DE; Sim-Selley LJ
    J Pharmacol Exp Ther; 2008 Feb; 324(2):664-73. PubMed ID: 17967938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Cannabinoid Agonists and Antagonists on Sleep and Breathing in Sprague-Dawley Rats.
    Calik MW; Carley DW
    Sleep; 2017 Sep; 40(9):. PubMed ID: 28934522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of chronic exposure to delta9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions.
    Romero J; Garcia-Palomero E; Castro JG; Garcia-Gil L; Ramos JA; Fernandez-Ruiz JJ
    Brain Res Mol Brain Res; 1997 Jun; 46(1-2):100-8. PubMed ID: 9191083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex-specific alterations in hippocampal cannabinoid 1 receptor expression following adolescent delta-9-tetrahydrocannabinol treatment in the rat.
    Silva L; Harte-Hargrove L; Izenwasser S; Frank A; Wade D; Dow-Edwards D
    Neurosci Lett; 2015 Aug; 602():89-94. PubMed ID: 26118897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of beta-arrestin1 deletion on acute cannabinoid activity, brain cannabinoid receptors and tolerance to cannabinoids in mice.
    Breivogel CS; Vaghela MS
    J Recept Signal Transduct Res; 2015 Feb; 35(1):98-106. PubMed ID: 25779032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic Administration of Cannabinoid Agonists ACEA, AM1241, and CP55,940 Induce Sex-Specific Differences in Tolerance and Sex Hormone Changes in a Chemotherapy-Induced Peripheral Neuropathy.
    Barnes RC; Blanton H; Dancel CL; Castro-Piedras I; Rorabaugh BR; Morgan DJ; Guindon J
    J Pharmacol Exp Ther; 2024 Oct; 391(2):258-271. PubMed ID: 38936979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sexually-dimorphic alterations in cannabinoid receptor density depend upon prenatal/early postnatal history.
    Dow-Edwards D; Frank A; Wade D; Weedon J; Izenwasser S
    Neurotoxicol Teratol; 2016; 58():31-39. PubMed ID: 27634313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of delta9-tetrahydrocannabinol physical dependence on brain cannabinoid receptors.
    Breivogel CS; Scates SM; Beletskaya IO; Lowery OB; Aceto MD; Martin BR
    Eur J Pharmacol; 2003 Jan; 459(2-3):139-50. PubMed ID: 12524139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.